How Peninsula biotech Vega Therapeutics looks to stanch a genetic bleeding disease
The startup, spun out of sibling biotech group in South San Francisco, expects to start a clinical trial in a rare bleeding disorder early next year.
Source: bizjournals.com Health Care:Physician Practices headlines - Category: American Health Authors: Ron Leuty Source Type: news
More News: American Health | Biotechnology | Bleeding | Clinical Trials | Genetics | Health Management